Harbor Capital Advisors Inc. reduced its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 90.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,172 shares of the real estate investment trust's stock after selling 20,902 shares during the period. Harbor Capital Advisors Inc.'s holdings in Healthpeak Properties were worth $44,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the stock. Mizuho Bank Ltd. acquired a new position in Healthpeak Properties during the fourth quarter worth approximately $28,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Healthpeak Properties during the 4th quarter valued at $30,000. Future Financial Wealth Managment LLC purchased a new stake in shares of Healthpeak Properties during the 1st quarter valued at $30,000. Covestor Ltd increased its holdings in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after buying an additional 1,152 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth $45,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have issued reports on DOC. Wedbush lowered their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. Wells Fargo & Company dropped their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Robert W. Baird reduced their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 29th. Finally, Argus reiterated a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $23.27.
View Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Up 0.1%
Healthpeak Properties stock traded up $0.02 during midday trading on Thursday, hitting $17.03. 5,383,938 shares of the stock were exchanged, compared to its average volume of 5,200,562. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.35 and a quick ratio of 1.35. The company has a 50 day moving average price of $17.64 and a two-hundred day moving average price of $19.33. The firm has a market cap of $11.83 billion, a P/E ratio of 42.59, a P/E/G ratio of 1.94 and a beta of 1.04. Healthpeak Properties, Inc. has a 1 year low of $16.64 and a 1 year high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The business had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the previous year, the firm posted $0.45 earnings per share. The company's revenue was up 15.9% compared to the same quarter last year. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were paid a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is currently 305.00%.
Insider Transactions at Healthpeak Properties
In related news, Director Tommy G. Thompson acquired 5,700 shares of the firm's stock in a transaction on Friday, May 9th. The stock was bought at an average cost of $17.36 per share, with a total value of $98,952.00. Following the acquisition, the director now directly owns 138,513 shares in the company, valued at approximately $2,404,585.68. The trade was a 4.29% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Scott M. Brinker bought 11,337 shares of the company's stock in a transaction dated Monday, April 28th. The stock was bought at an average cost of $17.68 per share, with a total value of $200,438.16. Following the transaction, the chief executive officer now directly owns 201,863 shares in the company, valued at approximately $3,568,937.84. The trade was a 5.95% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 29,764 shares of company stock valued at $521,909. 0.23% of the stock is currently owned by corporate insiders.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.